Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Statistics

Total Valuation

SHE:300246 has a market cap or net worth of CNY 2.23 billion. The enterprise value is 2.36 billion.

Market Cap	2.23B
Enterprise Value	2.36B

Important Dates

The next estimated earnings date is Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300246 has 261.60 million shares outstanding. The number of shares has decreased by -1.21% in one year.

Current Share Class	261.60M
Shares Outstanding	261.60M
Shares Change (YoY)	-1.21%
Shares Change (QoQ)	-1.47%
Owned by Insiders (%)	30.19%
Owned by Institutions (%)	5.02%
Float	182.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.13
PB Ratio	1.72
P/TBV Ratio	2.03
P/FCF Ratio	n/a
P/OCF Ratio	447.55
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-34.89
EV / Sales	2.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.60

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.49.

Current Ratio	2.19
Quick Ratio	1.64
Debt / Equity	0.49
Debt / EBITDA	n/a
Debt / FCF	-4.23
Interest Coverage	-2.83

Financial Efficiency

Return on equity (ROE) is -4.84% and return on invested capital (ROIC) is -2.37%.

Return on Equity (ROE)	-4.84%
Return on Assets (ROA)	-1.91%
Return on Invested Capital (ROIC)	-2.37%
Return on Capital Employed (ROCE)	-4.10%
Revenue Per Employee	784,601
Profits Per Employee	-50,646
Employee Count	1,335
Asset Turnover	0.42
Inventory Turnover	3.39

Taxes

Income Tax	-841,978
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.89% in the last 52 weeks. The beta is 0.32, so SHE:300246's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+40.89%
50-Day Moving Average	9.29
200-Day Moving Average	7.78
Relative Strength Index (RSI)	36.07
Average Volume (20 Days)	6,577,846

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300246 had revenue of CNY 1.05 billion and -67.61 million in losses. Loss per share was -0.26.

Revenue	1.05B
Gross Profit	262.46M
Operating Income	-76.46M
Pretax Income	-65.25M
Net Income	-67.61M
EBITDA	-15.86M
EBIT	-76.46M
Loss Per Share	-0.26

Balance Sheet

The company has 585.89 million in cash and 639.31 million in debt, giving a net cash position of -53.42 million or -0.20 per share.

Cash & Cash Equivalents	585.89M
Total Debt	639.31M
Net Cash	-53.42M
Net Cash Per Share	-0.20
Equity (Book Value)	1.30B
Book Value Per Share	4.67
Working Capital	642.30M

Cash Flow

In the last 12 months, operating cash flow was 4.99 million and capital expenditures -156.19 million, giving a free cash flow of -151.20 million.

Operating Cash Flow	4.99M
Capital Expenditures	-156.19M
Free Cash Flow	-151.20M
FCF Per Share	-0.58

Margins

Gross margin is 25.06%, with operating and profit margins of -7.30% and -6.46%.

Gross Margin	25.06%
Operating Margin	-7.30%
Pretax Margin	-6.23%
Profit Margin	-6.46%
EBITDA Margin	-1.51%
EBIT Margin	-7.30%
FCF Margin	n/a

Dividends & Yields

SHE:300246 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.21%
Shareholder Yield	n/a
Earnings Yield	-3.03%
FCF Yield	-6.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 25, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	May 25, 2023
Split Type	Forward
Split Ratio	1.5

Scores

SHE:300246 has an Altman Z-Score of 1.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.92
Piotroski F-Score	4